skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Aged remover assunto: Treatment Outcome remover Pharmacology. Drug Treatments remover Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Peginterferon alfa-2a: A review of approved and investigational uses
Peginterferon alfa-2a: A review of approved and investigational uses
Material Type:
Artigo 		Adicionar ao Meu Espaço

Peginterferon alfa-2a: A review of approved and investigational uses

Matthews, S.James ; McCoy, Christopher

Clinical therapeutics, 2004-07, Vol.26 (7), p.991-1025 [Periódico revisado por pares]

Belle Mead, NJ: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

ROSENBERG, Steven A ; YANG, James C ; MORTON, Kathleen E ; LAURENCOT, Carolyn M ; STEINBERG, Seth M ; WHITE, Donald E ; DUDLEY, Mark E ; SHERRY, Richard M ; KAMMULA, Udai S ; HUGHES, Marybeth S ; PHAN, Giao Q ; CITRIN, Deborah E ; RESTIFO, Nicholas P ; ROBBINS, Paul F ; WUNDERLICH, John R

Clinical cancer research, 2011-07, Vol.17 (13), p.4550-4557 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
3
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Loi, S. ; Michiels, S. ; Salgado, R. ; Sirtaine, N. ; Jose, V. ; Fumagalli, D. ; Kellokumpu-Lehtinen, P.-L. ; Bono, P. ; Kataja, V. ; Desmedt, C. ; Piccart, M.J. ; Loibl, S. ; Denkert, C. ; Smyth, M.J. ; Joensuu, H. ; Sotiriou, C.

Annals of oncology, 2014-08, Vol.25 (8), p.1544-1550 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements
Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements
Material Type:
Artigo 		Adicionar ao Meu Espaço

Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements

NISHINO, Mizuki ; GIOBBIE-HURDER, Anita ; GARGANO, Maria ; SUDA, Margaret ; RAMAIYA, Nikhil H ; HODI, F. Stephen

Clinical cancer research, 2013-07, Vol.19 (14), p.3936-3943 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
5
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study

Omrani, Ali S, FRCP ; Saad, Mustafa M, MD ; Baig, Kamran, MPH ; Bahloul, Abdelkarim, MD ; Abdul-Matin, Mohammed, FRCP ; Alaidaroos, Amal Y, MD ; Almakhlafi, Ghaleb A, MD ; Albarrak, Mohammed M, FRCPC ; Memish, Ziad A, Dr Prof ; Albarrak, Ali M, FRCPC

The Lancet infectious diseases, 2014-11, Vol.14 (11), p.1090-1095 [Periódico revisado por pares]

London: Lancet Publishing Group

Texto completo disponível

Citações Citado por
6
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

MAY, Margaret T ; GOMPELS, Mark ; CHADWICK, David ; MARTIN, Fabiola ; HILL, Teresa ; WALSH, John ; POST, Frank ; FISHER, Martin ; AINSWORTH, Jonathan ; JOSE, Sophie ; LEEN, Clifford ; NELSON, Mark ; DELPECH, Valerie ; ANDERSON, Jane ; SABIN, Caroline ; PORTER, Kholoud ; ORKIN, Chloe ; KEGG, Stephen ; HAY, Phillip ; JOHNSON, Margaret ; PALFREEMAN, Adrian ; GILSON, Richard

AIDS (London), 2014-05, Vol.28 (8), p.1193-1202 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
7
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

MASUDA, Hiroko ; BAGGERLY, Keith A ; FRASER SYMMANS, W ; UENO, Naoto T ; YING WANG ; YA ZHANG ; GONZALEZ-ANGULO, Ana Maria ; MERIC-BERNSTAM, Funda ; VALERO, Vicente ; LEHMANN, Brian D ; PIETENPOL, Jennifer A ; HORTOBAGYI, Gabriel N

Clinical cancer research, 2013-10, Vol.19 (19), p.5533-5540 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
8
Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation: The ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)
Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation: The ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation: The ASAP Study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)

REDDY, Vivek Y ; MÖBIUS-WINKLER, Sven ; MILLER, Marc A ; NEUZIL, Petr ; SCHULER, Gerhard ; WIEBE, Jens ; SICK, Peter ; SIEVERT, Horst

Journal of the American College of Cardiology, 2013-06, Vol.61 (25), p.2551-2556 [Periódico revisado por pares]

New York, NY: Elsevier

Texto completo disponível

Citações Citado por
9
Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody
Material Type:
Artigo 		Adicionar ao Meu Espaço

Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

LIPSON, Evan J ; SHARFMAN, William H ; PARDOLL, Drew M ; BRAHMER, Julie R ; TOPALIAN, Suzanne L ; DRAKE, Charles G ; WOLLNER, Ira ; TAUBE, Janis M ; ANDERS, Robert A ; HAIYING XU ; SHENG YAO ; PONS, Alice ; LIEPING CHEN

Clinical cancer research, 2013-01, Vol.19 (2), p.462-468 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por
10
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Material Type:
Artigo 		Adicionar ao Meu Espaço

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Stupp, Roger ; Wong, Eric T ; Kanner, Andrew A ; Steinberg, David ; Engelhard, Herbert ; Heidecke, Volkmar ; Kirson, Eilon D ; Taillibert, Sophie ; Liebermann, Frank ; Dbalý, Vladimir ; Ram, Zvi ; Villano, J. Lee ; Rainov, Nikolai ; Weinberg, Uri ; Schiff, David ; Kunschner, Lara ; Raizer, Jeffrey ; Honnorat, Jerome ; Sloan, Andrew ; Malkin, Mark ; Landolfi, Joseph C ; Payer, Franz ; Mehdorn, Maximilian ; Weil, Robert J ; Pannullo, Susan C ; Westphal, Manfred ; Smrcka, Martin ; Chin, Lawrence ; Kostron, Herwig ; Hofer, Silvia ; Bruce, Jeffrey ; Cosgrove, Rees ; Paleologous, Nina ; Palti, Yoram ; Gutin, Philip H

European journal of cancer (1990), 2012-09, Vol.48 (14), p.2192-2202 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (14.812)

Refinar Meus Resultados

Assunto 

  1. Life Sciences & Biomedicine  (15.278)
  2. Science & Technology  (15.278)
  3. Female  (13.974)
  4. Middle Aged  (13.930)
  5. Male  (13.254)
  6. Adult  (10.402)
  7. Aged, 80 And Over  (4.649)
  8. Oncology  (4.587)
  9. Antineoplastic Agents  (4.429)
  10. Pharmacology & Pharmacy  (3.024)
  11. Adolescent  (2.816)
  12. Double-Blind Method  (2.503)
  13. Follow-Up Studies  (2.341)
  14. Chemotherapy  (2.333)
  15. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1994  (220)
  2. 1994Até1998  (1.703)
  3. 1999Até2003  (4.782)
  4. 2004Até2009  (4.352)
  5. Após 2009  (4.223)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (2.307)
  2. Alemão  (10)
  3. Português  (2)
  4. Galês  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.